1. F23 Validity, reliability, ability to detect change and meaningful within-patient change of the CUHDRS. (September 2018) Authors: Trundell, Dylan; Palermo, Giuseppe; Schobel, Scott; Long, Jeffrey D; Leavitt, Blair R; Tabrizi, Sarah J Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 89(2018)Supplement 1 Page Start: A48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. F61 Digital, high-frequency, long-term monitoring of motor and non-motor symptoms in huntington's disease (hd) patients. (September 2018) Authors: Lipsmeier, Florian; Cheng, Wei-Yi; Wolf, Detlef; Zhang, Yan-Ping; Kilchenmann, Timothy; Bamdadian, Atieh; Smith, Anne; Wild, Edward; Schobel, Scott; Czech, Christian; Gossens, Christian; Lindemann, Michael Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 89(2018)Supplement 1 Page Start: A61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. J02 A global development program testing RG6042, an anti-sense oligonucleotide, for the treatment of early manifest huntington's disease (hd). (September 2018) Authors: Schobel, Scott; Palermo, Giuseppe; Trundell, Dylan; Kremer, Thomas; Sanwald-Ducray, Patricia; Smith, Anne; Boak, Lauren; Doody, Rachelle Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 89(2018)Supplement 1 Page Start: A98 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. F24 Design of a prospective, longitudinal, natural history study in huntington's disease. (September 2018) Authors: Hooper, Gregory; Trundell, Dylan; Palermo, Giuseppe; Kremer, Thomas; Frick, Elsbeth; Boak, Lauren; Doody, Rachelle; Schobel, Scott Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 89(2018)Supplement 1 Page Start: A48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. J01 Effects of IONIS-HTTRX (RG6042) in patients with early huntington's disease, results of the first htt-lowering drug trial. (September 2018) Authors: Tabrizi, Sarah J; Leavitt, Blair; Landwehrmeyer, Bernhard; Wild, Edward; Saft, Carsten; Barker, Roger; Craufurd, David; Rickards, Hugh; Rosser, Anne; Priller, Josef; Kordasiewicz, Holly; Czech, Christian; Swayze, Eric; Norris, Daniel A; Baumann, Tiffany; Gerlach, Irene; Schobel, Scott; Smith, Ann... Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 89(2018)Supplement 1 Page Start: A97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. D09 Parallel evaluation of mutant huntingtin and neurofilament light as biomarkers for huntington's disease: the hd-csf study. (September 2018) Authors: Byrne, Lauren M; Rodrigues, Filipe B; Johnson, Eileanoir B; Wijeratne, Peter A; Vita, Enrico De; Alexander, Daniel C; Czech, Christian; Schobel, Scott; Scahill, Rachael I; Heslegrave, Amanda; Zetterberg, Henrik; Wild, Edward J Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 89(2018)Supplement 1 Page Start: A34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 241 Intrathecal antisense oligonucleotide delivery in HD: experience from RG6042 programme and best practice considerations. Issue 6 (27th May 2022) Authors: Leavitt, Blair; Wild, Edward; Bang, Jee; Smith, Anne; Schlegel, Valerie; Schobel, Scott; Nicotra, Alessia; Landwehrmeyer, Bernhard; Tabrizi, Sarah Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 93:Issue 6(2022) Page Start: A83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A biological classification of Huntington's disease: the Integrated Staging System. Issue 7 (July 2022) Authors: Tabrizi, Sarah J; Schobel, Scott; Gantman, Emily C; Mansbach, Alexandra; Borowsky, Beth; Konstantinova, Pavlina; Mestre, Tiago A; Panagoulias, Jennifer; Ross, Christopher A; Zauderer, Maurice; Mullin, Ariana P; Romero, Klaus; Sivakumaran, Sudhir; Turner, Emily C; Long, Jeffrey D; Sampaio, Cristina Journal: Lancet neurology Issue: Volume 21:Issue 7(2022) Page Start: 632 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Linking amyloid to clinical outcome: A quantitative semi‐mechanistic model based on the A/T/N biomarker framework to simulate the natural history of Alzheimer's disease and the effects of anti‐amyloid treatment. (20th December 2022) Authors: Mazer, Norman A; Hofmann, Carsten; Lott, Dominik; Gieschke, Ronald; Klein, Gregory; Boess, Frank; Grimm, Hans Peter; Kerchner, Geoffrey A.; Baudler, Monika; Smith, Janice; Schobel, Scott; Doody, Rachelle S. Journal: Alzheimer's & dementia Issue: Volume 18(2022)Supplement 3 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Results and evaluation of a first‐in‐human study of RG7342, an mGlu5 positive allosteric modulator, utilizing Bayesian adaptive methods. (18th December 2017) Authors: Sturm, Stefan; Delporte, Marie‐Laure; Hadi, Salah; Schobel, Scott; Lindemann, Lothar; Weikert, Robert; Jaeschke, Georg; Derks, Michael; Palermo, Giuseppe Journal: British journal of clinical pharmacology Issue: Volume 84:Number 3(2018:Sep.) Page Start: 445 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗